CD8+T cell exhaustion mediated by exosome circCCAR1 can reduce the effective targets of the PD-1 pathway, thereby leading to primary resistance of HCC to anti-PD-1 therapy [81]. Here, CD8A is linked to hepatocellular carcinoma.